News

Please find below news from ODI Pharma AB. More stock relevant news can be found in the section "Stock Information" on the "INVESTORS" site.

Suche

ODI Pharma

Aug 26
4 Min.

ODI Pharma AB: Publication of year-end report for the financial year 2020/2021

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its year-end report for the fourth quarter and financial year 1st of July 2020 –...

0 Kommentare

ODI Pharma

Aug 17
3 Min.

ODI Pharma AB approves the official launch of kandol., an exclusive CBD infused skincare line

ODI Pharma AB (“ODI Pharma” or the “Company”), a producer and representative of finished pharmaceutical cannabis and cosmetics products,...

0 Kommentare

ODI Pharma

Juli 9
2 Min.

ODI Pharma AB: Flagging notification

ODI Pharma AB (“ODI Pharma”) has been informed that Mr. Niclas Kappelin has acquired 20’000 shares in ODI Pharma and exceeded the...

0 Kommentare

ODI Pharma

Mai 27
4 Min.

ODI Pharma AB: Publication of interim report for the third quarter 2020/2021

ODI Pharma AB (“ODI” or “the Company”) hereby publishes its interim report concerning the period July 2020 – March 2021. The report is...

0 Kommentare

ODI Pharma

Apr 21
3 Min.

ODI Pharma: Update on progress in “Project Poland” and “Project Skin”

In January 2021 and February 2021, ODI Pharma AB (“ODI” or the “Company”) announced the decision to expand its current business with...

0 Kommentare

ODI Pharma

Feb 25
4 Min.

ODI Pharma AB: Publication of half-year report 2020

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2020. The report is available...

0 Kommentare

ODI Pharma

Feb 22
2 Min.

ODI Pharma achieves milestone towards market entry in Poland

ODI Pharma AB (“ODI” or the “Company”) announces that its subsidiary ODI Pharma Polska Sp. z o.o. has finalized documentation and filed...

0 Kommentare

ODI Pharma

Jan 14
2 Min.

ODI Pharma proceeds with its plans and launches Project Skin

ODI Pharma AB (“ODI” or “the Company”) announces that the Board of Directors has decided to expand ODI’s current business with...

0 Kommentare

ODI Pharma

14. Dez 2020
3 Min.

Communique from the Annual General Meeting in ODI Pharma AB (publ)

This is an unofficial translation of a communique from the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish....

0 Kommentare

ODI Pharma

14. Dez 2020
2 Min.

Kommuniké från årsstämma i ODI Pharma AB (publ)

Idag den 14 december 2020, hölls årsstämma i ODI Pharma AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga...

0 Kommentare

ODI Pharma

27. Nov 2020
2 Min.

ODI Pharma AB: Publication of the interim report for Q1 2020

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report for the period July – September 2020. The report is available...

0 Kommentare

ODI Pharma

19. Nov 2020
1 Min.

ODI Pharma AB publishes the annual report for the fiscal year 2019/2020

The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI”) hereby publish the annual report of the fiscal year...

0 Kommentare

ODI Pharma

17. Nov 2020
3 Min.

ODI Pharma AB investigates the possibility to launch skin care products

ODI Pharma AB (“ODI” or “the Company”), through research carried out by its subsidiary ODI Pharma Schweiz AG, announces that the Company...

0 Kommentare

ODI Pharma

11. Nov 2020
5 Min.

Notice to Annual General Meeting in ODI Pharma AB (publ)

This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...

0 Kommentare

ODI Pharma

11. Nov 2020
4 Min.

Kallelse till årsstämma i ODI Pharma AB (publ)

Aktieägarna i ODI Pharma AB (publ), 559223–1392, kallas härmed till årsstämma måndagen den 14 december 2020 kl. 10.00 på Engelbrektsgatan...

0 Kommentare

ODI Pharma

2. Nov 2020
6 Min.

ODI PHARMA AB AND APHRIA INC. EXECUTE SUPPLY AGREEMENT

Stockholm, Sweden and Leamington, Ontario – November 2nd, 2020 – ODI Pharma AB (“ODI”, ISIN SE0013409760) today announced that, despite...

0 Kommentare

ODI Pharma

27. Aug 2020
3 Min.

ODI Pharma AB: Publication of year-end report

ODI Pharma AB (“ODI” or “the Company”) hereby publishes its year-end report for the period July 2019 – June 2020. The report is available...

0 Kommentare

ODI Pharma

28. Mai 2020
1 Min.

ODI Pharma AB: update – missing MAR label in quarterly report

ODI Pharma AB (“ODI” or “the Company”) gives an update regarding that a MAR label was missing in the quarterly report published 28th of...

0 Kommentare

ODI Pharma

28. Mai 2020
3 Min.

ODI Pharma AB: Publication of interim report for the first quarter 2020

ODI Pharma AB (“ODI” or “the Company”) hereby publishes its interim report for the period July 2019 – March 2020. The report is available...

0 Kommentare

ODI Pharma

7. Apr 2020
2 Min.

ODI Pharma AB: Status update in connection to COVID-19

ODI Pharma AB (“ODI” or “the Company”) hereby announces that the Board of Directors does not see any impact on the Company’s mid- and...

0 Kommentare